SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · IEX Real-Time Price · USD
0.436
+0.031 (7.60%)
At close: Apr 22, 2024, 4:00 PM
0.446
+0.010 (2.23%)
After-hours: Apr 22, 2024, 7:49 PM EDT
SeaStar Medical Holding Market Cap
SeaStar Medical Holding has a market cap or net worth of $28.39 million as of April 22, 2024. Its market cap has increased by 3.24% in one year.
Market Cap
28.39M
Enterprise Value
37.30M
1-Year Change
3.24%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since January 26, 2021, SeaStar Medical Holding's market cap has decreased from $98.30M to $28.39M, a decrease of -71.12%. That is a compound annual growth rate of -31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 19, 2024 | 30.50M | -25.06% |
| Apr 18, 2024 | 40.70M | -22.77% |
| Apr 17, 2024 | 52.70M | -1.50% |
| Apr 16, 2024 | 53.50M | 118.37% |
| Apr 15, 2024 | 24.50M | -7.55% |
| Apr 12, 2024 | 26.50M | -0.38% |
| Apr 11, 2024 | 26.60M | 4.31% |
| Apr 10, 2024 | 25.50M | 9.91% |
| Apr 9, 2024 | 23.20M | -4.92% |
| Apr 8, 2024 | 24.40M | -5.43% |
| Apr 5, 2024 | 25.80M | -2.27% |
| Apr 4, 2024 | 26.40M | -4.00% |
| Apr 3, 2024 | 27.50M | -1.08% |
| Apr 2, 2024 | 27.80M | -5.76% |
| Apr 1, 2024 | 29.50M | 8.86% |
| Mar 28, 2024 | 27.10M | 3.44% |
| Mar 27, 2024 | 26.20M | -4.73% |
| Mar 26, 2024 | 27.50M | -4.51% |
| Mar 25, 2024 | 28.80M | -2.37% |
| Mar 22, 2024 | 29.50M | 3.15% |
| Mar 21, 2024 | 28.60M | -3.70% |
| Mar 20, 2024 | 29.70M | -5.41% |
| Mar 19, 2024 | 31.40M | 3.97% |
| Mar 18, 2024 | 30.20M | -4.13% |
| Mar 15, 2024 | 31.50M | 3.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DURECT | 27.04M |
| Acasti Pharma | 26.98M |
| BioVie | 26.72M |
| Forte Biosciences | 26.71M |
| Serina Therapeutics | 26.62M |
| Oncternal Therapeutics | 26.22M |
| Sol-Gel Technologies | 26.19M |
| NKGen Biotech | 25.22M |